Australia Begins 12-Month Human Trial of COVID-19 Vaccine, as Countries Race to Find a Cure – VICE

This article originally appeared on VICE US.
Australian health officials have commenced human trials of a potential COVID-19 vaccine developed by the University of Queensland (UQ), with researchers announcing on Monday that healthy adult volunteers had received their first dose at a clinic in Brisbane.
The Phase 1 trial of the vaccine will involve about 120 volunteers, aged 18 to 55, each of whom will be injected with two doses of the vaccine every four weeks. Some will receive a placebo, and all will be closely and regularly monitored for a 12-month period while the safety and immune response of the vaccine is analysed. Volunteers will need to maintain the same social distancing and hygiene practises as everyone else.
Preliminary results are expected to be released by the end of September.
We expect to have preliminary results after about three months, and if all goes well, we can move as fast as we can to the next stage in the vaccines development, said Professor Paul Young, co-leader of the project. That

Click here to view the original article.